Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

Clinical trial NCT01644110 · COMPLETED

Trial details

NCT number: NCT01644110
Sponsor: University of Ulm
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Secondary Myelofibrosis PMF SMF Post-PV MF Post-ET MF

Start date: 2013-08-01
Primary completion: 2024-04-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.